Comparison of Aprepitant with combinations of Dexamethasone-Ondansetron and Aprepitant-Dexamethasone-Ondansetron for preventing nausea and vomiting after gynecological laparoscopic surgery

Not Applicable

• Conditions: Health Condition 1: null- 1. adults between 20-50 years age 2. those undergoing day-care gynecological laparoscopy 3. ASA class 1-2

• Registration Number: CTRI/2018/05/013879
• Lead Sponsor: Jawaharlal Institute of Postgraduate Medical Education and Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. female patients aged 20-50 years

2. ASA class 1 or 2

3. procedure- gynecological laparoscopy

Exclusion Criteria

1. cardiovascular, respiratory, gastrointestinal diseases, diabetes

2. previous history of postoperative nausea and vomiting

3. pre-operative use of antiemetics or opioids

4. pregnancy

5. allergy to any of the three drugs under study

6. NPO inadequate

Study & Design

• Study Type: Interventional
• Study Design: Not specified